63 articles, transcripts, and reports
The financial performance of Abbott Laboratories (NYSE: ABT) has been positively impacted by the high demand for COVID-related diagnostic services. However, in a sign that…
Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert B. Ford — President and…
Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert B. Ford — President…
Abbott Laboratories (NYSE: ABT) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations, Licensing and Acquisitions Robert B.…
Thanks to the COVID-19 testing growth, after reporting solid second quarter results and strong outlook for fiscal 2020 last Thursday, shares of Abbott Laboratories (NYSE:…
Abbott Laboratories (NYSE: ABT) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert B. Ford — President…
Abbott Laboratories (NYSE: ABT) reported second-quarter financial results before the regular trading hours on Thursday. Revenue for the quarter fell 8% to b $7.3 billion,…
Abbott Laboratories (ABT) Q1 2020 earnings call dated Apr. 16, 2020 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations, Licensing and Acquisitions Robert B. Ford — President…
Abbott Laboratories (NYSE: ABT) reported its financial results for the quarter ended March 31, 2020 today. The company reported a 16% drop in earnings for…
When Wall Street suffered huge losses after business activity was disrupted across the country due to the COVID-19 outbreak, one industry that remained relatively resilient…
